California looks to take lead in combating pay-for-delay settlements
Federal lawmakers have tried unsuccessfully for years to pass legislation to curb pay-for-delay agreements where branded drugmakers pay rivals to keep generic drugs from coming to market. Now, a California state...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: